Table 2.
Case No. | Age (yrs) | Presenting Symptom | Imaging Finding | CA 125 (U/mL) | CA 19-9 (U/mL) | Clinical Impression | Surgical Treatment | Adjuvant Treatment | Recurrence | Treatment for Recurrence | DFS (mos) | Status | OS (mos) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 42 | Pelvic mass | 7.4-cm cystic right ovarian mass with internal solid nodules | 72.5 | 80.1 | Ovarian clear cell carcinoma | TH with BSO, PLND, PALND, peritonectomy, and omentectomy (PDS) | – | Lung, liver, and peritoneum | PLND, PALND, peritonectomy, omentectomy, appendectomy, and hepatectomy (SDS), and chemotherapy | 13 | Dead | 39 |
2 | 53 | – | 4.8-cm cystic left ovarian mass with small enhancing nodules | 26.8 | NA | Ovarian borderline tumor or carcinoma | TH with BSO, PLND, peritonectomy, and omentectomy (PDS) | Chemotherapy | – | – | 21 | Alive (NED) | 21 |
3 | 57 | Abdominal distension | 10.9-cm cystic left ovarian mass with solid component | 12.2 | 25.4 | Ovarian borderline tumor or carcinoma | BSO with PLNS, peritonectomy, and omentectomy (PDS) | Chemotherapy | – | – | 11 | Alive (NED) | 11 |
4 | 61 | Pelvic mass | Solid and cystic left ovarian mass showing intense hypermetabolic activity | NA | NA | Ovarian carcinoma | TH with BSO, PLND, PALND, peritoneal biopsy, and omentectomy (PDS) | Chemotherapy | NA (follow-up loss) | NA | NA | NA | NA |
5 | 52 | Pelvic mass | 5.8-cm solid mass involving the right lateral uterine wall | 108.8 | 9.3 | Uterine leiomyoma or LMS | TH with BSO and peritonectomy (PDS) | Chemotherapy | – | – | 53 | Alive (NED) | 53 |
Abbreviations: BSO, bilateral salpingo-oophorectomy; CA 19-9, cancer antigen 19-9; CA 125, cancer antigen 125; DFS, disease-free survival; LMS, leiomyosarcoma; mos, months; NA, not applicable; NED, no evidence of disease; OS, overall survival; PALND, para-aortic lymph node dissection; PDS, primary debulking surgery; PLND, pelvic lymph node dissection; PLNS, pelvic lymph node sampling; SDS, secondary debulking surgery; TH, total hysterectomy; yrs, years; –, absent.